Year |
Citation |
Score |
2004 |
Chantal S, Braun CM, Bouchard RW, Labelle M, Boulanger Y. Similar 1H magnetic resonance spectroscopic metabolic pattern in the medial temporal lobes of patients with mild cognitive impairment and Alzheimer disease. Brain Research. 1003: 26-35. PMID 15019560 DOI: 10.1016/J.Brainres.2003.11.074 |
0.516 |
|
2002 |
Braun CM, Boulanger Y, Labelle M, Khiat A, Dumont M, Mailloux C. Brain metabolic differences as a function of hemisphere, writing hand preference, and gender. Laterality. 7: 97-113. PMID 15513191 DOI: 10.1080/13576500143000212 |
0.464 |
|
2002 |
Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Archives of Neurology. 59: 955-62. PMID 12056931 DOI: 10.1001/Archneur.59.6.955 |
0.515 |
|
2001 |
Labelle M, Khiat A, Durocher A, Boulanger Y. Comparison of metabolite levels and water diffusion between cortical and subcortical strokes as monitored by MRI and MRS. Investigative Radiology. 36: 155-63. PMID 11228579 DOI: 10.1097/00004424-200103000-00004 |
0.459 |
|
2000 |
Boulanger Y, Labelle M, Khiat A. Role of phospholipase A(2) on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Research. Brain Research Reviews. 33: 380-9. PMID 11011072 DOI: 10.1016/S0165-0173(00)00037-0 |
0.506 |
|
1998 |
Khiat A, Labelle M, Boulanger Y. Three-dimensional structure of the Y1 receptor agonist [Leu31, Pro34]NPY as determined by NMR and molecular modeling. The Journal of Peptide Research : Official Journal of the American Peptide Society. 51: 317-22. PMID 9560007 DOI: 10.1111/J.1399-3011.1998.Tb00429.X |
0.463 |
|
1997 |
Labelle M, Boulanger Y, Fournier A, St Pierre S, Savard R. Tissue-specific regulation of fat cell lipolysis by NPY in 6-OHDA-treated rats. Peptides. 18: 801-8. PMID 9285928 DOI: 10.1016/S0196-9781(97)00028-4 |
0.43 |
|
1997 |
Labelle M, St-Pierre S, Savard R, Boulanger Y. Solution structure of neuropeptide tyrosine 13-36, a Y2 receptor agonist, as determined by NMR. European Journal of Biochemistry / Febs. 246: 780-5. PMID 9219539 |
0.476 |
|
Show low-probability matches. |